Jim Nicklin

The Functional Assessment of Cancer-Vulva: Reliability and Validity (2005)

Janda, Monika, Obermair, Andreas, Cella, David, Perrin, Lewis, Nicklin, Jim, Gordon-Ward, Bruce, ...

Objectives: To assess the reliability and validity of the Functional Assessment of Cancer Therapy-Vulvar (FACT-V). Methods: Seventy-seven patients treated between January 1996 and January 2001 for...

The Functional Assessment of Cancer-Vulva: Reliability and Validity (2005)

Janda, Monika, Obermair, Andreas, Cella, David, Perrin, Lewis, Nicklin, Jim, Gordon-Ward, Bruce, ...

Objectives: To assess the reliability and validity of the Functional Assessment of Cancer Therapy-Vulvar (FACT-V). Methods: Seventy-seven patients treated between January 1996 and January 2001 for...

The Functional Assessment of Cancer-Vulva: Reliability and Validity (2005)

Janda, Monika, Obermair, Andreas, Cella, David, Perrin, Lewis, Nicklin, Jim, Gordon-Ward, Bruce, ...

Objectives: To assess the reliability and validity of the Functional Assessment of Cancer Therapy-Vulvar (FACT-V). Methods: Seventy-seven patients treated between January 1996 and January 2001 for...

The Functional Assessment of Cancer-Vulva: Reliability and Validity (2005)

Janda, Monika, Obermair, Andreas, Cella, David, Perrin, Lewis, Nicklin, Jim, Gordon-Ward, Bruce, ...

Objectives: To assess the reliability and validity of the Functional Assessment of Cancer Therapy-Vulvar (FACT-V). Methods: Seventy-seven patients treated between January 1996 and January 2001 for...

The Functional Assessment of Cancer-Vulva: Reliability and Validity (2005)

Janda, Monika, Obermair, Andreas, Cella, David, Perrin, Lewis, Nicklin, Jim, Gordon-Ward, Bruce, ...

Objectives: To assess the reliability and validity of the Functional Assessment of Cancer Therapy-Vulvar (FACT-V). Methods: Seventy-seven patients treated between January 1996 and January 2001 for...

The Functional Assessment of Cancer-Vulva: Reliability and Validity (2005)

Janda, Monika, Obermair, Andreas, Cella, David, Perrin, Lewis, Nicklin, Jim, Gordon-Ward, Bruce, ...

Objectives: To assess the reliability and validity of the Functional Assessment of Cancer Therapy-Vulvar (FACT-V). Methods: Seventy-seven patients treated between January 1996 and January 2001 for...

The Functional Assessment of Cancer-Vulva: Reliability and Validity (2005)

Janda, Monika, Obermair, Andreas, Cella, David, Perrin, Lewis, Nicklin, Jim, Gordon-Ward, Bruce, ...

Objectives: To assess the reliability and validity of the Functional Assessment of Cancer Therapy-Vulvar (FACT-V). Methods: Seventy-seven patients treated between January 1996 and January 2001 for...

The Functional Assessment of Cancer-Vulva: Reliability and Validity (2005)

Janda, Monika, Obermair, Andreas, Cella, David, Perrin, Lewis, Nicklin, Jim, Gordon-Ward, Bruce, ...

Objectives: To assess the reliability and validity of the Functional Assessment of Cancer Therapy-Vulvar (FACT-V). Methods: Seventy-seven patients treated between January 1996 and January 2001 for...

Differential Splicing of KLK5 and KLK7 in Epithelial Ovarian Cancer Produces Novel Variants with Potential as Cancer Biomarkers (2003)

Dong, Ying, Kaushal, Aneel, Brattsand, Maria, Nicklin, Jim, Clements, Judith A.

Purpose: The wild-type or variant mRNAs of several kallikrein (KLK) genes, such as KLK4, are highly expressed in ovarian carcinomas and may have potential as tumor markers. Two of these KLK genes...

Differential Splicing of KLK5 and KLK7 in Epithelial Ovarian Cancer Produces Novel Variants with Potential as Cancer Biomarkers (2003)

Dong, Ying, Kaushal, Aneel, Brattsand, Maria, Nicklin, Jim, Clements, Judith A.

Purpose: The wild-type or variant mRNAs of several kallikrein (KLK) genes, such as KLK4, are highly expressed in ovarian carcinomas and may have potential as tumor markers. Two of these KLK genes...

Differential Splicing of KLK5 and KLK7 in Epithelial Ovarian Cancer Produces Novel Variants with Potential as Cancer Biomarkers (2003)

Dong, Ying, Kaushal, Aneel, Brattsand, Maria, Nicklin, Jim, Clements, Judith A.

Purpose: The wild-type or variant mRNAs of several kallikrein (KLK) genes, such as KLK4, are highly expressed in ovarian carcinomas and may have potential as tumor markers. Two of these KLK genes...

Differential Splicing of KLK5 and KLK7 in Epithelial Ovarian Cancer Produces Novel Variants with Potential as Cancer Biomarkers (2003)

Dong, Ying, Kaushal, Aneel, Brattsand, Maria, Nicklin, Jim, Clements, Judith A.

Purpose: The wild-type or variant mRNAs of several kallikrein (KLK) genes, such as KLK4, are highly expressed in ovarian carcinomas and may have potential as tumor markers. Two of these KLK genes...

Differential Splicing of KLK5 and KLK7 in Epithelial Ovarian Cancer Produces Novel Variants with Potential as Cancer Biomarkers (2003)

Dong, Ying, Kaushal, Aneel, Brattsand, Maria, Nicklin, Jim, Clements, Judith A.

Purpose: The wild-type or variant mRNAs of several kallikrein (KLK) genes, such as KLK4, are highly expressed in ovarian carcinomas and may have potential as tumor markers. Two of these KLK genes...

Differential Splicing of KLK5 and KLK7 in Epithelial Ovarian Cancer Produces Novel Variants with Potential as Cancer Biomarkers (2003)

Dong, Ying, Kaushal, Aneel, Brattsand, Maria, Nicklin, Jim, Clements, Judith A.

Purpose: The wild-type or variant mRNAs of several kallikrein (KLK) genes, such as KLK4, are highly expressed in ovarian carcinomas and may have potential as tumor markers. Two of these KLK genes...

Differential Splicing of KLK5 and KLK7 in Epithelial Ovarian Cancer Produces Novel Variants with Potential as Cancer Biomarkers (2003)

Dong, Ying, Kaushal, Aneel, Brattsand, Maria, Nicklin, Jim, Clements, Judith A.

Purpose: The wild-type or variant mRNAs of several kallikrein (KLK) genes, such as KLK4, are highly expressed in ovarian carcinomas and may have potential as tumor markers. Two of these KLK genes...

Differential Splicing of KLK5 and KLK7 in Epithelial Ovarian Cancer Produces Novel Variants with Potential as Cancer Biomarkers (2003)

Dong, Ying, Kaushal, Aneel, Brattsand, Maria, Nicklin, Jim, Clements, Judith A.

Purpose: The wild-type or variant mRNAs of several kallikrein (KLK) genes, such as KLK4, are highly expressed in ovarian carcinomas and may have potential as tumor markers. Two of these KLK genes...

Human Kallikrein 4 (KLK4) Is Highly Expressed in Serous Ovarian Carcinomas (2001)

Dong, Ying, Kaushal, Aneel, Chu, Simon, Bui, Loan T., Fuller, Peter J., Nicklin, Jim, ...

Previous studies indicated that a new member of the human kallikrein (KLK) gene family, KLK4, was expressed in prostate, breast, and endometrial carcinoma cell lines and may have potential as a tumor...

Human Kallikrein 4 (KLK4) Is Highly Expressed in Serous Ovarian Carcinomas (2001)

Dong, Ying, Kaushal, Aneel, Chu, Simon, Bui, Loan T., Fuller, Peter J., Nicklin, Jim, ...

Previous studies indicated that a new member of the human kallikrein (KLK) gene family, KLK4, was expressed in prostate, breast, and endometrial carcinoma cell lines and may have potential as a tumor...

Human Kallikrein 4 (KLK4) Is Highly Expressed in Serous Ovarian Carcinomas (2001)

Dong, Ying, Kaushal, Aneel, Chu, Simon, Bui, Loan T., Fuller, Peter J., Nicklin, Jim, ...

Previous studies indicated that a new member of the human kallikrein (KLK) gene family, KLK4, was expressed in prostate, breast, and endometrial carcinoma cell lines and may have potential as a tumor...

Human Kallikrein 4 (KLK4) Is Highly Expressed in Serous Ovarian Carcinomas (2001)

Dong, Ying, Kaushal, Aneel, Chu, Simon, Bui, Loan T., Fuller, Peter J., Nicklin, Jim, ...

Previous studies indicated that a new member of the human kallikrein (KLK) gene family, KLK4, was expressed in prostate, breast, and endometrial carcinoma cell lines and may have potential as a tumor...

Human Kallikrein 4 (KLK4) Is Highly Expressed in Serous Ovarian Carcinomas (2001)

Dong, Ying, Kaushal, Aneel, Chu, Simon, Bui, Loan T., Fuller, Peter J., Nicklin, Jim, ...

Previous studies indicated that a new member of the human kallikrein (KLK) gene family, KLK4, was expressed in prostate, breast, and endometrial carcinoma cell lines and may have potential as a tumor...

Human Kallikrein 4 (KLK4) Is Highly Expressed in Serous Ovarian Carcinomas (2001)

Dong, Ying, Kaushal, Aneel, Chu, Simon, Bui, Loan T., Fuller, Peter J., Nicklin, Jim, ...

Previous studies indicated that a new member of the human kallikrein (KLK) gene family, KLK4, was expressed in prostate, breast, and endometrial carcinoma cell lines and may have potential as a tumor...

Human Kallikrein 4 (KLK4) Is Highly Expressed in Serous Ovarian Carcinomas (2001)

Dong, Ying, Kaushal, Aneel, Chu, Simon, Bui, Loan T., Fuller, Peter J., Nicklin, Jim, ...

Previous studies indicated that a new member of the human kallikrein (KLK) gene family, KLK4, was expressed in prostate, breast, and endometrial carcinoma cell lines and may have potential as a tumor...

Human Kallikrein 4 (KLK4) Is Highly Expressed in Serous Ovarian Carcinomas (2001)

Dong, Ying, Kaushal, Aneel, Chu, Simon, Bui, Loan T., Fuller, Peter J., Nicklin, Jim, ...

Previous studies indicated that a new member of the human kallikrein (KLK) gene family, KLK4, was expressed in prostate, breast, and endometrial carcinoma cell lines and may have potential as a tumor...

Human Kallikrein 4 (KLK4) Is Highly Expressed in Serous Ovarian Carcinomas (2001)

Dong, Ying, Kaushal, Aneel, Chu, Simon, Bui, Loan T., Fuller, Peter J., Nicklin, Jim, ...

Previous studies indicated that a new member of the human kallikrein (KLK) gene family, KLK4, was expressed in prostate, breast, and endometrial carcinoma cell lines and may have potential as a tumor...